Incorporation of iloprost in phospholipase-resistant phospholipid scaffold enhances its barrier protective effects on pulmonary endothelium
PublisherNature Publishing Group
MetadataShow full item record
AbstractCorrection of barrier dysfunction and inflammation in acute lung injury (ALI) represents an important problem. Previous studies demonstrate barrier-protective and anti-inflammatory effects of bioactive lipid prostacyclin and its stable analog iloprost (ILO). We generated a phospholipase resistant synthetic phospholipid with iloprost attached at the sn-2 position (ILO-PC) and investigated its biological effects. In comparison to free ILO, ILO-PC caused sustained endothelial cell (EC) barrier enhancement, linked to more prolonged activation of Rap1 and Rac1 GTPases and their cytoskeletal and cell junction effectors: cortactin, PAK1, p120-catenin and VE-cadherin. ILO and ILO-PC equally efficiently suppressed acute, Rho GTPase-dependent EC hyper-permeability caused by thrombin. However, ILO-PC exhibited more sustained barrier-protective and anti-inflammatory effects in the model of chronic EC dysfunction caused by bacterial wall lipopolysacharide (LPS). ILO-PC was also more potent inhibitor of NFκB signaling and lung vascular leak in the murine model of LPS-induced ALI. Treatment with ILO-PC showed more efficient ALI recovery over 3 days after LPS challenge than free ILO. In conclusion, this study describes a novel synthetic phospholipid with barrier-enhancing and anti-inflammatory properties superior to existing prostacyclin analogs, which may be used as a prototype for future development of more efficient treatment for ALI and other vascular leak syndromes. Copyright 2018 The Author(s).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85041402722&doi=10.1038%2fs41598-018-19197-1&partnerID=40&md5=c3f8c04cbfa2b6514728ede6a1684761; http://hdl.handle.net/10713/9400
- VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost.
- Authors: Birukova AA, Tian Y, Dubrovskyi O, Zebda N, Sarich N, Tian X, Wang Y, Birukov KG
- Issue date: 2012 Oct
- Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1.
- Authors: Birukova AA, Meng F, Tian Y, Meliton A, Sarich N, Quilliam LA, Birukov KG
- Issue date: 2015 May
- Rap1 mediates protective effects of iloprost against ventilator-induced lung injury.
- Authors: Birukova AA, Fu P, Xing J, Birukov KG
- Issue date: 2009 Dec
- Regulation of lung endothelial permeability and inflammatory responses by prostaglandin A2: role of EP4 receptor.
- Authors: Ohmura T, Tian Y, Sarich N, Ke Y, Meliton A, Shah AS, Andreasson K, Birukov KG, Birukova AA
- Issue date: 2017 Jun 15
- Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces and Thrombin Receptor Activating Peptide 6.
- Authors: Meliton A, Meng F, Tian Y, Shah AA, Birukova AA, Birukov KG
- Issue date: 2015 Dec